KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LifeMD (LFMD) Operating Income (2016 - 2025)

LifeMD filings provide 14 years of Operating Income readings, the most recent being -$6.2 million for Q4 2025.

  • On a quarterly basis, Operating Income fell 4.26% to -$6.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.5 million, a 71.09% increase, with the full-year FY2025 number at -$7.7 million, up 62.41% from a year prior.
  • Operating Income hit -$6.2 million in Q4 2025 for LifeMD, down from -$2.0 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $2.2 million in Q1 2025 to a low of -$16.1 million in Q2 2021.
  • Median Operating Income over the past 5 years was -$6.2 million (2024), compared with a mean of -$7.1 million.
  • Biggest five-year swings in Operating Income: plummeted 584.76% in 2021 and later surged 134.94% in 2025.
  • LifeMD's Operating Income stood at -$13.7 million in 2021, then rose by 24.1% to -$10.4 million in 2022, then surged by 79.06% to -$2.2 million in 2023, then crashed by 174.87% to -$6.0 million in 2024, then dropped by 4.26% to -$6.2 million in 2025.
  • The last three reported values for Operating Income were -$6.2 million (Q4 2025), -$2.0 million (Q3 2025), and -$451562.0 (Q2 2025) per Business Quant data.